Economic development creates opportunities to grow state, local and metro areas, which are essential for economic growth, improved quality of life and community development. Biotechnology articles below.
The investment will bring capital improvements, expansion of manufacturing capacity and capabilities, and advanced technology to the company's DeSoto, KS operations.
The world-class biotech research hub in Huntsville, AL has marshalled its resources to fight the pandemic, with increased lab space.
The global healthcare company will create 300 jobs at a new specialized blood plasma facility and logistics center at its Clayton, NC campus.
The University of Alabama at Birmingham is collaborating with biopharm company Altimmune for preclinical testing of a potential vaccine to prevent COVID-19 disease.
Scientists and researchers in Alabama are engaged in the global effort to stem threats posed by the novel coronavirus/COVID-19.
Indiana-based Eli Lilly and Company will create more than 460 new jobs at its new manufacturing pharmaceutical facility in Durham, NC.
The expansions by three biotech firms will create 135 new direct jobs at the University of New Orleans and the New Orleans BioInnovation Center.
Industry analysts are predicting that 2018 will turn out to be a banner year for merger and acquisition activity in the biotech/pharma sector, with up to $200 billion in assets changing hands.
The 30,000-square foot facility — a collaborative effort by Johnson & Johnson Innovation, New York State and New York Genome Center — will have capacity for up to 30 life science startups focused on biotech, pharmaceutical, medical devices and consumer health.
A $1.8 million specialized biotech startup and a $10 million expansion of Coldstream Labs’ pharmaceutical plant are the most recent additions to Lexington’s growing biotech cluster.
A $2.8-million investment from Innovate NY—matched by $21.5 million in private equity—is spurring the development of a biotech cluster in New York City.
Technology and biotechnology companies around New Jersey invested more than $51 million in 2015.
The New Jersey Economic Development Authority (NJ EDA) has approved 41 companies to share a total of $47.4 million through the state’s Technology Business Tax Certificate Transfer (NOL) Program in FY 2016.
New Jersey Lt. Governor Kim Guadagno discusses the Garden State's growing biotech/pharma industry and workforce training programs.
JLL’s 2015 Life Sciences Outlook Report identifies top global destinations for talent, sales, science and the trends driving international growth